Firebrick Pharma (ASX:FRE) raised around AU$800,000 via a share purchase plan at AU$0.055 apiece, according to a Thursday filing with the Australian bourse.
The pharmaceutical firm raised AU$635,600 following the completion of its share purchase plan comprising the issue of roughly 11.6 million fully paid ordinary shares.
Further, the company received commitments or applications for an additional AU$158,700 worth of shares. Settlement is expected to occur by Oct. 15.
Proceeds will be used to fund Firebrick Pharma's marketing initiatives for Nasodine nasal spray in Singapore and the US, the filing stated.
Firebrick Pharma's shares were up more than 7% in recent trade.
Price (AUD): $0.06, Change: $+0.0040, Percent Change: +7.27%
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。